Sponsor

Changzhou No.2 People's Hospital

Clinical research sponsor

Published trials5

Recruiting shown1

Roles2

SourceClinicalTrials.gov

Clinical trials

5 shown

FMT+Immunotherapy+Chemotherapy As First-line Treatment for Driver-gene Negative Advanced NSCLCNCT06403111 · lead sponsor · 2024-06-01

UNKNOWN

Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study)NCT07083154 · collaborator · 2025-09-27

RECRUITING

LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 DiabetesNCT05313529 · collaborator · 2022-10-08

COMPLETED

Anlotinib Hydrochloride Combined With EGFR TKIs in Advanced Non-small Cell Lung CancerNCT03766490 · collaborator · 2019-03-30

UNKNOWN

Efficacy and Safety of Saxagliptin VS. Glimepiride in Chinese T2DM Patients Controlled Inadequately With MetforminNCT02280486 · collaborator · 2015-01-01

COMPLETED

Sponsor roles

collaborator4

lead sponsor1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.